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Cyclosporin A is an immunosuppressive agent
known to cause hirsutism. The mechanisms of action
that cause hirsutism have not been fully elucidated,
however. We have previously reported that several
selective protein kinase C inhibitors promote the
growth of murine hair epithelial cells and stimulate
anagen induction. In this paper, we report on an
investigation of the mechanisms of action of hair-
growing activity possessed by cyclosporin A from
the viewpoint of whether it promotes hair epithelial
cell growth or whether it modulates the expression
or translocation of protein kinase C isozymes in hair
epithelial cells. Our results indicate that cyclosporin
A (over a wide dosage range of 1±1000 ng per ml)
stimulates cultured murine hair epithelial cell growth
to about 150%±160% relative to controls. We also
observed growth-promoting effects on murine epi-
dermal keratinocytes (about 140%) at the dose range
of 1±100 ng per ml. At high dose ranges above 3 mg
per ml, the growth of both cells was inhibited. On
the other hand, we found that cyclosporin A reduces
the overall expression of protein kinase C a, bI, and
bII in cultured murine hair epithelial cells, and
reduces the levels of protein kinase C a, bI, bII, and
h in the particulate fraction from cultured murine
hair epithelial cells. From these results, we speculate
that the hair-growing activity of cyclosporin A is at
least partially attributable to its growth-promoting
in¯uence on hair epithelial cells sequential to its
downregulation of some protein kinase C isozymes
in hair epithelial cells or inhibition of translocation
of some protein kinase C isozymes to the membrane
or cytoskeleton of hair epithelial cells. Key words:
baldness/hair follicles/hair growth/keratinocytes. J Invest
Dermatol 117:605±611, 2001
C
yclosporin A is a highly lipophilic cyclic undecapep-
tide, produced by the fungus Trichoderma polysporum
(Link ex Pers.) Rifai, Cylindrocarpon lucidum Booth,
and Tolypocladium in¯atum Gams (Borel et al, 1976;
Dreyfuss et al, 1976; StaÈhelin, 1986). It is known to
possess a variety of biologic and physiologic actions such as
antiparasitic, fungicidal, anti-in¯ammatory effects, and immuno-
suppressive properties. Up to now, it has been used in medical
treatment as an immunosuppressant after organ transplantation and
as a cure for several autoimmune disorders such as psoriasis, atopic
dermatitis, BehcËet's disease, and myasthenia gravis. In addition,
cyclosporin A is known to cause hirsutism as a side-effect (Laupacis,
1983; Harper et al, 1984; Wysocki and Daley, 1987). Its hair-
growing effects have been examined by in vitro and in vivo
experiments by several researchers. It has been shown that topical
and intraperitoneal cyclosporin A administration induces anagen
hair formation in C57BL-6 mice (Paus et al, 1989; 1996) and it has
also been shown that oral (Sawada et al, 1987; Buhl et al, 1990),
topical, and subcutaneous (Watanabe et al, 1991) administration of
cyclosporin A causes hair growth on nude mice. Moreover, its
effects on male pattern baldness in humans have been investigated
by several researchers (Picascia and Roenigk, 1987; 1988; Gilhar et
al, 1990; Lutz, 1994). The mechanisms of action of its hair-growing
activity have not yet been fully described, however (Paus et al,
1996). There are at present no data to support the hypothesis that
cyclosporin A can directly stimulate hair epithelial cell proliferation.
Only one piece of data exists that implies that cyclosporin A
prolongs the anagen phase of the hair cycle, assumed from the fact
that cyclosporin A prolongs the term of hair shaft growth in the hair
follicle tissue organ culture system (Taylor et al, 1993). On the
other hand, it is reported that cyclosporin A has cytostatic effects on
epidermal keratinocytes (Furue et al, 1988; Nickoloff et al, 1988). In
this report, we investigated the effect of cyclosporin A on cultured
hair epithelial cell growth.
It has been reported that protein kinase C (PKC) acts as a
negative hair-growing factor (Harmon et al, 1995; 1997; Xiong and
Harmon, 1997; Takahashi et al, 2000). In this report, we examine
whether cyclosporin A, which possesses hair-growing effects, has an
in¯uence on PKC expression or translocation in hair epithelial cells.
PKC is a major signal transduction pathway in many tissues and
cells, and is known to play a key role in cell differentiation and
proliferation (Blobe et al, 1996). The role of PKC in hair follicle
tissue has not been elucidated, however. PKC was ®rst identi®ed
and characterized by Nishizuka in 1977 as a serine threonine kinase
(Nishizuka et al, 1978; Nishizuka, 1989). Up to now, at least 12
isozymes have been isolated. PKC is now classi®ed into three major
subgroups. The ®rst group is conventional PKC (a, bI, bII, and g),
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which is calcium- and diacylglycerol-dependent. The second group
is novel PKC (d, e, h, and q) whose activity is calcium-independent
but diacylglycerol-dependent. The third group is atypical PKC (z,
l, i, and m) whose activity is calcium- and diacylglycerol-
independent (Quest, 1996). There is as yet limited information,
however, on PKC isozyme expression in hair follicles. In human
hair follicles, expression of PKC-a, PKC-b, PKC-d, and PKC-z
has been con®rmed in cultured outer root sheath keratinocytes
(Hoffmann et al, 1996), and expression of PKC-a in mice (Wang
and Smart, 1999) and PKC-h in humans (Koizumi et al, 1993;
Wollina, 1997) has been con®rmed in outer root sheaths in
immunohistochemical studies. We examined the expression and
translocation of PKC-a, PKC-bI, PKC-bII, and PKC-h in
cultured murine hair epithelial cells.
The mechanism of action by which cyclosporin A causes its
immunosuppressive effects has been a major focus of research
interest. Cyclosporin A is known to block activation of T cells by
blocking interleukin-2 (IL-2) production (Buurman et al, 1986).
Up to now, as the targets of cyclosporin A, at least two routes have
been proposed that lead to inhibition of IL-2 production. One is
the cyclophilin±calcineurin±NFAT (nuclear factor of activated T
cells) route. It has been elucidated that cyclosporin A binds to
cyclophilin (cis±trans peptidyl±prolyl isomerase) (Fischer et al, 1989;
Takahashi et al, 1989; Friedman and Weissman, 1991), an
intracellular receptor, and this complex binds to and inhibits the
calcium- and calmodulin-dependent phosphatase calcineurin (Liu et
al, 1991), which is known to regulate the translocation of the
transcription factor NFAT to the nucleus (Flanagan et al, 1991),
resulting in prevention of IL-2 gene transcription (Elliott et al,
1984; Granelli-Piperno et al, 1984; KroÈnke et al, 1984). Another
hypothesis involves the phospholipid metabolism PKC route.
Cyclosporin A has been shown to be associated with PKC isozyme
induction in lymphocytes (Kimball et al, 1993). Prevention of the
activation of some PKC isozymes such as PKC-b is hypothesized as
the mechanism by which cyclosporin A inhibits IL-2 synthesis and
proliferation in stimulated human lymphocytes (Szamel et al, 1993).
We investigated the effect of cyclosporin A on the expression and
translocation of PKC isozymes in hair epithelial cells.
In this report, we discuss the hypothesis that the hair-growing
activity of cyclosporin A is related to its downregulation or
inhibition of translocation of some PKC isozymes in hair epithelial
cells.
MATERIALS AND METHODS
Materials Cyclosporin A was purchased from Sigma (St. Louis, MO).
Antihuman rabbit polyclonal antibodies against PKC-a, PKC-bI, PKC-
bII, and PKC-h were purchased from Santa Cruz Biotechnology (Santa
Cruz, CA). The second antibody used was biotinylated goat antirabbit
immunoglobulins purchased from DAKO (Glostrup, Denmark).
Streptavidin±horseradish peroxidase conjugate was purchased from
Amersham Pharmacia Biotech (Little Chalfont, Buckinghamshire, U.K.).
Isolation and culturing of murine hair epithelial cells Murine hair
epithelial cells were isolated and cultured according to the method
reported by Tanigaki et al (1990) with suitable modi®cations. The dorsal
skin was peeled from 4-d-old C3H/HeNCrj mice (Charles River Japan,
Kanagawa, Japan), cut into approximately 5 mm widths, washed three
times with Eagle's minimum essential medium (MEM) containing 60 mg
per liter of kanamycin and 10% fetal bovine serum (FBS), and then
dipped into MEM containing 750 IU per ml of dispase (from Bacillus
polymyxa; Godo Shusei, Tokyo, Japan), 60 mg per liter of kanamycin,
and 10% FBS at 4°C for 20 h. After washing with Dulbecco's
phosphate-buffered calcium- and magnesium-free saline (PBS) containing
50,000 U per liter of penicillin and 50 mg per liter of streptomycin
(PBS±PS), the epidermis was peeled off and the remaining dermis layer
was washed three times with PBS±PS and dispersed in Dulbecco's
modi®ed Eagle's medium (DMEM) containing 0.25% collagenase (from
Streptomyces parvulus; Nitta Gelatin, Osaka, Japan), 50,000 U per liter of
penicillin, 50 mg per liter of streptomycin, 0.5% bovine serum albumin,
and 20% FBS at 37°C for 1 h, stirring occasionally. This dermis
suspension was ®ltered through a 212 mm nylon mesh, and the ®ltrate
was centrifuged at 1400 rpm for 7 min. The pellet was then resuspended
in PBS±PS. The suspension was left to stand for 15 min, allowing the
hair follicle tissue to precipitate due to the difference in speci®c gravity,
after which the supernatant was removed using an aspirator. The hair
follicle tissue was resuspended in PBS±PS and then precipitated. This
precipitation process was repeated three times. Finally, the hair follicle
tissue was incubated in 0.05% ethylenediamine tetraacetic acid (EDTA)±
0.25% trypsin in Hanks' balanced calcium- and magnesium-free salt
solution (HBSS) (Life Technologies, MD) at 37°C for 5 min. The hair
follicle cells were suspended in DMEM supplemented with 50,000 U per
liter of penicillin, 50 mg per liter of streptomycin, and 10% FBS at a
density of 2 3 105 cells per ml after ®ltration via a 212 mm nylon mesh.
This hair follicle cell suspension was pipetted into a 24-well type I
collagen-coated plate (2 cm2 per well; Iwaki Glass, Chiba, Japan) at a
rate of 1 ml per well (1 3 105 cells per cm2) and incubated in a
humidi®ed atmosphere containing 5% CO2 at 37°C for 24 h. After 24 h
incubation, the medium was exchanged with MCDB153 (Sigma) (Boyce
and Ham, 1983) containing 5 mg per liter of bovine insulin, 5 mg per
liter of mouse epidermal growth factor, 40 mg per liter of bovine
pituitary extract, 10 mg per liter of human transferrin, 0.4 mg per liter of
hydrocortisone, 0.63 mg per liter of progesterone, 14 mg per liter of O-
phosphorylethanolamine, 6.1 mg per liter of ethanolamine, 50,000 U per
liter of penicillin, and 50 mg per liter of streptomycin after washing with
PBS. It was then further incubated in a humidi®ed atmosphere
containing 5% CO2 at 37°C for 5 d. During incubation, the medium
was removed and replaced with fresh medium every other day.
Isolation and culturing of mouse epidermal keratinocytes The
dorsal skin was peeled from 4-d-old C3H/HeNCrj mice (Charles River
Japan), cut into approximately 5 mm widths, washed three times with
MEM containing 60 mg per liter of kanamycin and 10% FBS, and then
dipped into MEM containing 750 IU per ml of dispase (from Bacillus
polymyxa; Godo Shusei), 60 mg per liter of kanamycin, and 10% FBS at
4°C for 20 h. After washing with PBS±PS, the epidermis was peeled off,
washed ®ve times with PBS±PS, and then immersed in 0.05% EDTA±
0.25% trypsin in HBSS at 37°C for 10 min, stirring occasionally. After
10 min, DMEM (supplemented with 50,000 U per liter of penicillin,
50 mg per liter of streptomycin, and 10% FBS) was added, and the
suspension was ®ltered through a 212 mm nylon mesh, followed by
centrifugation at 1500 rpm for 5 min. The keratinocytes thus obtained
were suspended in DMEM supplemented with 50,000 U per liter of
penicillin, 50 mg per liter of streptomycin, and 10% FBS, pipetted into a
24-well type I collagen-coated plate (2 cm2 per well; Iwaki Glass) at an
initial cell density of 1 3 105 cells per cm2, and incubated in a
humidi®ed atmosphere containing 5% CO2 at 37°C for 24 h. After 24 h
incubation, the medium was exchanged with MCDB153 containing the
same additives as those for the hair epithelial cells after washing with
PBS. It was then further incubated in a humidi®ed atmosphere
containing 5% CO2 at 37°C for 5 d. During incubation, the medium
was removed and replaced with fresh medium every other day.
Colorimetric assay for cell proliferation by MTT The degree of
cell growth was determined by means of an MTT [3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay
(Carmichael et al, 1987). MTT reagent (Sigma) was dissolved in PBS at a
concentration of 5 mg per ml, ®ltered through a 0.45 mm membrane
®lter (cellulose acetate, DISMIC-13 cp; Advantec, Tokyo, Japan), and
added 10% (vol/vol) to the culture medium. The culture plate was
further incubated in a humidi®ed atmosphere containing 5% CO2 at
37°C for 4 h. After removing the medium, the formed dye was
extracted with acidic isopropanol containing 0.04 N HCl (adding 1.0 ml
per 2 cm2 well), and the absorbance was measured at 570 nm relative to
640 nm.
Immunoblot analysis (Western blotting) Cultured hair epithelial
cells were washed twice with PBS, treated for a few minutes with 0.05%
trypsin (Sigma) dissolved in PBS, and, after addition of an equal amount
of 0.06% trypsin inhibitor dissolved in PBS (from soybean, inhibiting
activity of 1.4 mg of trypsin per 1.0 mg; Sigma), scraped, and
centrifuged (1500 rpm, 5 min). The resultant cell pellet was sonicated in
®ve 10 s bursts in Buffer A [20 mM Tris(hydroxymethyl)aminomethane
(Tris) HCl (pH 7.5), 2 mM EDTA, 10 mM ethyleneglycol-bis(b-
aminoethyl ether)-N,N,N¢,N¢-tetraacetic acid, 0.25 M sucrose, 2 mM
phenylmethylsulfonyl ¯uoride, 10 mg per ml leupeptin, and 10 mM 2-
mercaptoethanol, ®nal concentrations] and centrifuged at 100,000 3 g
for 60 min (4°C). The supernatants were concentrated to 1/10 volume
using an ultra®lter (M.W. 30,000 cutting, UFP2 TTK; Millipore, MA)
and stored as the cytosol fraction at ±80°C. The pellets were then
dissolved in Buffer B [Buffer A + 0.5% (wt/vol) polyoxyethylene (10)
octylphenyl ether (Triton X-100)], sonicated in ®ve 10 s bursts, and
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centrifuged at 100,000 3 g for 60 min (4°C). The supernatants were
concentrated to 1/10 volume using an ultra®lter (M.W. 30,000 cutting,
UFP2 TTK; Millipore) and stored as the particulate fraction at ±80°C.
Protein concentrations were determined spectrophotometrically using a
DC-Protein Assay kit (Bio-Rad, CA).
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE) was performed according to the method of Laemmli (1970).
Aliquots (10 mg of protein per lane) of the cytosol or particulate fractions
were mixed with sample buffer (0.125 M Tris-HCl (pH 6.8), 2% (wt/
vol) SDS, 10% (wt/vol) glycerol, and 5% (vol/vol) 2-mercaptoethanol,
®nal concentrations), heated at 98°C for 3 min, and subjected to SDS-
PAGE using 7.5% polyacrylamide gel (Pagel NPU-7.5; Atto, Tokyo,
Japan). Protein standards for molecular weight were as follows: phos-
phorylase B, 97.4 kDa; bovine serum albumin, 68.0 kDa; ovalbumin,
46.0 kDa; carbonic anhydrase, 31.0 kDa; trypsin inhibitor, 20.1 kDa;
lysozyme, 14.4 kDa (ECL protein molecular weight markers, Amersham
Pharmacia Biotech). The proteins were electro-blotted onto a nitrocellu-
lose membrane (Schleicher & Schuell, Keene, NH) using a submarine
transfer apparatus (Trans-Blot Cell, Bio-Rad) for 3 h at 60 V/320 cm2
(Towbin et al, 1979). The transfer buffer conditions were as follows:
25 mM Tris-HCl (pH 8.3), 192 mM glycine, and 20% (vol/vol)
methanol. The blocking was performed on a rocking platform in a
solution containing 5% bovine serum albumin and 0.1% (wt/vol)
polyoxyethylene (20) sorbitan monolaurate (Tween 20) in PBS (PBS-T)
for 1 h at room temperature, and the membranes were then washed with
PBS-T for 5 min (three times). Next, the membranes were incubated
overnight at 4°C with diluted polyclonal antibodies (antihuman rabbit
antibodies, 3500 dilution by the blocking solution) against PKC
isozymes (a, bI, bII, and h). The membranes were then washed with
PBS-T, incubated with biotinylated goat antirabbit immunoglobulins
(33000 dilution by PBS-T) for 1 h at room temperature, and washed
with PBS-T. Next, the membranes were incubated with streptavidin±
horseradish peroxidase conjugate (31000 dilution with PBS-T) for 1 h
at room temperature and then washed with PBS-T. Detection of
immunoreactive protein was achieved by chemiluminescence using the
ECL Western blotting detection system (Amersham Pharmacia Biotech)
and exposed to X-ray ®lm (RX-U, Fuji Photo Film, Tokyo, Japan).
Protein bands were identi®ed as PKC by their molecular weight,
comigration with their standard proteins (PKC-a, PKC-bI, PKC-bII,
and PKC-h; human recombinant; Calbiochem-Novabiochem, CA), and
lack of staining by the secondary antibody when the primary antibody
was omitted. Quantitative analysis of PKC isozyme expression was
performed by densitometry (CS-9000; Shimadzu, Kyoto, Japan).
RESULTS
Cyclosporin A promotes the growth of both hair epithelial
cells and epidermal keratinocytes at the optimum
concentration It is reported that cyclosporin A inhibits the
Figure 1. Cyclosporin A promotes the growth of cultured
murine hair epithelial cells. Growth-promoting activities relative to
controls (= 100%) are shown. Cyclosporin A dissolved in methanol was
added in a volume of 1/100 to the culture medium during the 5 d
culture period. For the control, we used a medium to which an amount
of 1/100 volume of methanol was added. Results are represented as the
mean 6 SD (n = 6) carried out with primary cultures prepared from 50
neonatal mice. These results were con®rmed in four additional
experiments.
Figure 2. Micrographs of cultured hair epithelial cells (a, b, c) and epidermal keratinocytes (d, e) isolated and cultured from C3H mice
dorsal skin. Cells were cultured for 5 d in the presence (b, 10 ng per ml; c, e, 3 mg per ml) and absence (a, d) of cyclosporin A. Cyclosporin A
dissolved in methanol was added in a volume of 1/100 to the culture medium (b, c, e) during the 5 d culture period. For the control (a, d), we used a
medium to which an amount of 1/100 volume of methanol was added. (a) Control of cultured murine hair epithelial cells; (b) murine hair epithelial
cells cultured in the presence of 10 ng per ml of cyclosporin A; (c) murine hair epithelial cells cultured in the presence of 3 mg per ml of cyclosporin A;
(d) control of cultured murine epidermal keratinocytes; (e) murine epidermal keratinocytes cultured in the presence of 3 mg per ml of cyclosporin A.
Scale bars: 100 mm.
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growth of epidermal keratinocytes (Furue et al, 1988; Nickoloff et
al, 1988). We compared the effects of cyclosporin A on epidermal
keratinocyte and hair epithelial cell growth. Our results con®rmed
that cyclosporin A promotes cultured murine hair epithelial cell
growth at about 150%±160% relative to controls over the wide
concentration range of 1±1000 ng per ml. At a high dose of 3 mg
per ml of cyclosporin A, hair epithelial cell growth was partially
inhibited; and hair epithelial cell growth was completely inhibited
above a cyclosporin A concentration of 10 mg per ml (Fig 1). We
observed morphologic changes, such as elongation and
vacuolization, in hair epithelial cells incubated in 3 mg per ml of
cyclosporin A (Fig 2c). We also con®rmed that cyclosporin A
promotes murine epidermal keratinocyte growth at about 140%
relative to controls over the wide concentration range of 1±100 ng
per ml and partially inhibits the growth of epidermal keratinocytes
at concentrations of 1±3 mg per ml. Epidermal keratinocyte growth
was completely inhibited above a cyclosporin A concentration of
10 mg per ml (Fig 3). We observed morphologic changes, such as
enlargement and vacuolization, in epidermal keratinocytes
incubated with 3 mg per ml of cyclosporin A (Fig 2e).
Cyclosporin A dramatically decreases the levels of PKC-a,
PKC-bI, PKC-bII, and PKC-h in the particulate fraction of
cultured hair epithelial cells We examined the effect of
cyclosporin A on the expression of PKC isozymes in cultured
murine hair epithelial cells using Western blotting. The hair
epithelial cells were incubated with 0.1 mg per ml and 1.0 mg per
ml of cyclosporin A for the ®nal 48 h of the 5 d culture period. The
doses of cyclosporin A for the investigation of PKC protein levels
were set at 1.0 mg per ml, at which hair epithelial cells show
maximum growth-promoting activity, and its 10% concentration,
i.e., 0.1 mg per ml.
We observed signi®cant decreases in the overall expression of
PKC-a, PKC-bI, and PKC-bII in hair epithelial cells cultured in
media containing 0.1 mg per ml or 1.0 mg per ml of cyclosporin A
(c2 test for independence; p < 0.001 for PKC-a, PKC-bI, and
PKC-bII); the rate of decrease at 1.0 mg per ml was higher than
that at 0.1 mg per ml in all these cases; conversely, the overall
expression of PKC-h in hair epithelial cells cultured in media
containing 0.1 mg per ml and 1.0 mg per ml of cyclosporin A both
increased about 1.5-fold relative to the controls.
Figure 3. Cyclosporin A promotes the growth of cultured
murine epidermal keratinocytes. Growth-promoting activities relative
to controls (= 100%) are shown. Cyclosporin A dissolved in methanol
was added in a volume of 1/100 to the culture medium during the 5 d
culture period. For the control, we used a medium to which an amount
of 1/100 volume of methanol was added. Results are represented as the
mean 6 SD (n = 6) carried out with primary cultures prepared from 50
neonatal mice. These results were con®rmed in four additional
experiments.
Figure 4. Cyclosporin A dramatically decreases the levels of
PKC-a, PKC-bI, PKC-bII, and PKC-h in the particulate fraction
of cultured murine hair epithelial cells. Western blotting analysis is
shown for PKC-a, PKC-bI, PKC-bII, and PKC-h in cytosol and
particulate fractions extracted from cultured murine hair epithelial cells.
Cyclosporin A (0.1 mg per ml and 1.0 mg per ml) was added to the
culture medium during the ®nal 48 h of the 5 d culture period.
Cyclosporin A dissolved in methanol was added in a volume of 1/100 to
the culture medium. For the control, we used a medium to which an
amount of 1/100 volume of methanol was added. The data show the
cytosol fraction of the control (lane 1), the cytosol fraction of 0.1 mg per
ml cyclosporin A (lane 2), the cytosol fraction of 1.0 mg per ml
cyclosporin A (lane 3), the particulate fraction of the control (lane 4), the
particulate fraction of 0.1 mg per ml cyclosporin A (lane 5), and the
particulate fraction of 1.0 mg per ml cyclosporin A (lane 6). Speci®c
immunoreactive 80 kDa bands for PKC-a, PKC-bI, PKC-bII, and
PKC-h were detected. These results were con®rmed in an additional
experiment.
Figure 5. Densitometric analysis of the results of Western
blotting shown in Fig 4. Cyclosporin A dramatically decreases the
levels of PKC-a, PKC-bI, PKC-bII, and PKC-h in the particulate
fraction of cultured murine hair epithelial cells; and also suppresses the
overall expression of PKC-a, PKC-bI, and PKC-bII in cultured murine
hair epithelial cells. Cyclosporin A (0.1 mg per ml and 1.0 mg per ml)
was added to the culture medium during the ®nal 48 h of the 5 d
culture period. (a) PKC-a; (b) PKC-bI; (c) PKC-bII; (d) PKC-h. Square,
cytosol fraction; triangle, particulate fraction; diamond, overall = cytosol
fraction + particulate fraction. The level of overall expression of each
PKC isozyme in the controls (cyclosporin A = 0 mg per ml) is
represented as 100.
608 TAKAHASHI AND KAMIMURA THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
We observed signi®cant decreases in the levels of PKC-a, PKC-
bI, PKC-bII, and PKC-h in the particulate fraction of hair
epithelial cells cultured in media containing 0.1 mg per ml or
1.0 mg per ml of cyclosporin A (c2 test for independence; p < 0.001
for PKC-a, PKC-bI, PKC-bII, and PKC-h). The rate of decrease
at 1.0 mg per ml was higher than that at 0.1 mg per ml in all these
cases.
As a result of the addition of 0.1 mg per ml of cyclosporin A, the
level of PKC-bI in the cytosol fraction of hair epithelial cells
decreased. As a result of the addition of 1.0 mg per ml cyclosporin
A, the levels of PKC-a, PKC-bI, and PKC-bII in the cytosol
fraction of hair epithelial cells decreased. Addition of 0.1 mg per ml
and 1.0 mg per ml cyclosporin A led to increased levels of PKC-h
in the cytosol fraction of hair epithelial cells (Figs 4, 5).
DISCUSSION
Reports of the effects of cyclosporin A describe its growth-
inhibiting action on normal human epidermal keratinocytes
(Nickoloff et al, 1988) and on murine epidermal keratinocytes
and keratinocyte cell lines (Furue et al, 1988); and the G1 arrest of
the cell cycle has been inferred as being the mechanism of the
proliferative inhibition of keratinocytes by cyclosporin A (Khandke
et al, 1991). We observed growth-promoting action on hair
epithelial cells by cyclosporin A of about 150%±160% relative to
the controls at the optimum dose range of 1±1000 ng per ml,
however; at the same time, growth-promoting action on epidermal
keratinocytes (about 140% relative to the controls) was observed at
the dose range of 1±100 ng per ml, although the effect was
relatively weaker than that on the hair epithelial cells. In both cases,
a growth-inhibiting effect was observed at a high dose range (over
the 3 mg per ml range), which is consistent with previous reports
(Furue et al, 1988; Nickoloff et al, 1988; Khandke et al, 1991).
Morphologic changes triggered by cyclosporin A such as
vacuolization were reported in the A431 human squamous cell
carcinoma cell line (Furue et al, 1988) and in normal human
keratinocytes (Nickoloff et al, 1988) incubated with 10 mg per ml of
cyclosporin A. We also observed morphologic changes both in
epidermal keratinocytes and in hair epithelial cells at 3 mg per ml of
cyclosporin A; at a cyclosporin A level of 10 mg per ml, all the cells
died, in the case of both epidermal keratinocytes and hair epithelial
cells. Consequently, in both the epidermal keratinocytes and hair
epithelial cells, growth-promoting action by cyclosporin A was
observed at the speci®c common dose range of 1±100 ng per ml.
Concerning the similarity of the effects on growth of both
epidermal keratinocytes and hair epithelial cells induced by this
compound, this is a predictable result because both types of cells are
of the same origin from the viewpoint of the genesis of the
epidermis and hair. Slight differences exist, however, between the
two types of cells in their response to cyclosporin A. In clinical
treatments using cyclosporin A, the blood level of cyclosporin A is
closely controlled by a doctor in the range of 80±220 ng per ml so
as not to cause any side-effects (Uchida et al, 1988). In psoriatic
patients under cyclosporin A treatment, its concentration in wet
epidermis was calculated by Fisher et al (1988) to be 1±3 mg per ml.
Although it cannot be stated that the concentration of cyclosporin
A in a cultured medium directly corresponds to the blood level or
tissue level in vivo, it is logical to infer that the same substance causes
hirsutism and cures psoriasis, if we compare the effects of
cyclosporin A on the hair epithelial cells and epidermal
keratinocytes at the cyclosporin A concentration level of 1 mg
per ml in a medium. More speci®cally, at the cyclosporin A
concentration level of 1 mg per ml in a medium, the growth of hair
epithelial cells is improved, whereas no growth-promoting effect is
observed in epidermal keratinocytes. We suggest that the difference
in growth curves between the two types of cells when responding
to the same dose of cyclosporin A holds the key to understanding
the pharmacologic effects of cyclosporin A.
It has been reported that PKC acts as a negative hair-growing
factor (Harmon et al, 1995, 1997; Xiong and Harmon, 1997). Li et
al examined the levels of PKC-a and PKC-d in BALB/c mice back
skin in the course of hair growth induced by diphencyprone (Li et
al, 1999a) and hair plucking (Li et al, 1999b), and concluded that
the downregulation of PKC-a expression in skin appears to cause
anagen induction in the hair cycle progression. Takahashi et al
(1999) reported that procyanidin oligomers selectively and inten-
sively promote murine hair epithelial cell growth in vitro and
stimulate anagen induction in vivo. It is speculated that the hair-
growing activity of procyanidins is linked to their PKC inhibitory
activity based on the fact that several other selective PKC inhibitors
also exhibit hair-growing activity (Takahashi et al, 2000).
Cyclosporin A is known to block the activation of T cells by
blocking IL-2 production (Buurman et al, 1986). One of several
recognized views is that the target of cyclosporin A in signal
transduction, which causes inhibition of IL-2 production, is the
cyclophilin±calcineurin±NFAT route. On the other hand, a
phospholipid metabolism±PKC signal transduction route has also
been suggested (Szamel et al, 1993) as the target of cyclosporin A.
As for the enzymatic inhibition of PKC by cyclosporin A, there are
both positive and negative reports. Walker et al (1989) reported that
cyclosporin A inhibits the PKC in renal tubular epithelial cells in an
in vitro enzyme assay system using the cytosol fraction of the cell.
On the other hand, Wenzel-Seifert et al (1994) reported that
cyclosporin A did not directly inhibit recombinant PKC isozymes
(a, bI, g, d, e, and z) or PKC puri®ed from rat brain (a, bI, bII, and
g). Besides the direct inhibition of PKC enzymatic activity, Gupta
et al (1992) reported the effect of downregulation of PKC-a and
PKC-b expression by cyclosporin A in human lymphocytes.
Szamel et al (1993) reported that cyclosporin A speci®cally inhibits
the activation and translocation of PKC-b to the plasma membrane
in human lymphocytes, and demonstrated that this is caused by
inhibiting the activation of lysophosphatid acyltransferase-catalyzed
elevated incorporation of cis-polyunsaturated fatty acids into plasma
membrane phospholipids that is necessary for the activation of PKC
(Sekiguchi et al, 1988; Asaoka et al, 1992). Kimball et al (1993)
pointed out that cyclosporin A inhibits induction of the ``activator
of DNA replication'' (ADR) activated by PKC in a cell-free assay
system. Hassan et al (1997) examined in human lymphocytes the
relation of PKC-b activation and intracellular accumulation of IL-
2, which is inhibited by cyclosporin A, and concluded that
activation of PKC-b is critical for IL-2 accumulation and that the
target of cyclosporin A lies between the membrane signal and PKC.
We have examined for the ®rst time the effect of cyclosporin A
on PKC expression and translocation in murine hair epithelial cells.
Our results indicate that cyclosporin A inhibits the overall
expression of PKC-a, PKC-bI, and PKC-bII, and that cyclosporin
A increases the overall expression of PKC-h in cultured murine
hair epithelial cells. Moreover, we clari®ed that cyclosporin A
decreases the levels of PKC-a, PKC-bI, PKC-bII, and PKC-h in
the particulate fraction of cultured murine hair epithelial cells. It is
known that PKC distribution undergoes changes during cell
activation. For example, PKC-a, PKC-bII (human promyelocytic
leukemia cell line HL60) (Hocevar and Fields, 1991), and PKC-h
(RAW 264.7 macrophages) (Chen et al, 1997) are known to
translocate to the plasma membrane in response to phorbol ester
stimulation. PKC-bI and PKC-bII are known to translocate to the
membrane fraction and cytoskeletal fraction after phorbol ester
treatment in human megakaryoblastic leukemia cell line MEG-01
(Nagata et al, 1996). The accumulation of PKC-a in the
endoplasmic reticulum, the translocation of PKC-bI to the ruf¯ed
membrane edges, and the association of PKC-bII with actin-rich
micro®laments of the cytoskeleton are known to increase as results
of phorbol ester stimulation in PKC isozyme overexpressing NIH
3T3 ®broblasts (Goodnight et al, 1995). PKC-h is reported to be
present in the rough endoplasmic reticulum and outer nuclear
membrane in normal human keratinocytes (Chida et al, 1994). It is
considered that cyclosporin A affects intracellular localization of at
least these four PKC isozymes (a, bI, bII, and h) and modulates
interactions with membranes, the cytoskeleton, or with distinct
subcellular compartments, followed by initiation of cellular reac-
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tions such as mitogenesis and differentiation or speci®c cellular
responses such as changes in speci®c gene expression or changes in
secretion of growth factors, cytokines, or other cellular factors.
Experiments using ascomycin and rapamycin have shown that
inhibition of cyclophilin and calcineurin is not required for new
hair growth (Iwabuchi et al, 1995). Our results demonstrate for the
®rst time that cyclosporin A can stimulate hair epithelial cell
proliferation in cell culture systems at the optimum concentration.
We also found that cyclosporin A causes modulation in the
expression and translocation of PKC isozymes (a, bI, bII, and h) in
hair epithelial cells. Our results, combined with those of other
investigations, suggest a possible link between hair-growing activity
and PKC downregulation (a, bI, and bII) or inhibition of
translocation (a, bI, bII, and h) of some PKC isozymes by
cyclosporin A. Further investigations of other PKC isozymes will
provide useful information about whether selective PKC isozyme
expression is involved in the regulation of hair epithelial cell
proliferation, differentiation, and hair cycle regulation.
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